The COVID-19 pandemic and its wider implications affect everyone, in the UK and around the world. As the response to the COVID-19 crisis matures, attention is increasingly turning to ensuring treatments and other relevant technologies are coming through the development pipeline to help fight the virus in years to come. Here, we ask you to submit your project to keep this openly available registry of UK research programmes in preclinical drug development for COVID-19 up-to-date, relevant and useful.
This database helps researchers, funders and policy makers visualise what is happening and understand the landscape at a glance. This project aims to accelerate the development of new therapeutics, foster collaboration and communication, facilitate reagent and methodology sharing, and highlight fresh opportunities for innovative new research.
We are appealing to all those working on a pre-clinical therapeutic research project to take the time to update this database, and continue to keep it updated throughout the duration of the pandemic. We welcome and encourage contributions of a range of types from both academia and industry. We are interested in collating information on two main types of research:
- Preclinical drug discovery and development for COVID-19, covering all modalities, mechanisms of action and therapeutic targets.
- Supporting technologies that will inform and support drug development, including the development of assays, cell models, animal models and specialist reagents.
To find out more about the Academy of Medical Sciences and our work to support the research response to COVID-19, please visit our website.
Thank you for your participation.